The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

George L. Bakris

University of Chicago

Pritzker School of Medicine

Chicago

IL 60637

USA

[email]@earthlink.net

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • University of Chicago, Pritzker School of Medicine, Chicago, IL 60637, USA. 2008
  • Hypertensive Diseases Unit, Department of Medicine, Pritzker School of Medicine, University of Chicago, USA. 2007 - 2008
  • Hypertension Unit, Section of Endocrinology, Diabetes, and Metabolism, USA. 2006 - 2008
  • Department of Preventive Medicine, Rush University Hypertension Center, Chicago, USA. 2003 - 2007
  • University of Chicago School of Medicine, Department of Medicine, Hypertensive Diseases Unit, Chicago, USA. 2007
  • Rush University Medical Center, Chicago, Illinois 60612, USA. 2005 - 2006

References

  1. Combined therapy with a calcium channel blocker and an angiotensin II type 1 receptor blocker. Bakris, G.L. J. Clin. Hypertens. (Greenwich) (2008) [Pubmed]
  2. Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study. Bakris, G.L., Toto, R.D., McCullough, P.A., Rocha, R., Purkayastha, D., Davis, P. Kidney Int. (2008) [Pubmed]
  3. Reversal of diuretic-associated impaired glucose tolerance and new-onset diabetes: results of the STAR-LET study. Bakris, G., Molitch, M., Zhou, Q., Sarafidis, P., Champion, A., Bacher, P., Sowers, J.R. J. Cardiometab. Syndr (2008) [Pubmed]
  4. Achieving blood pressure goals globally: five core actions for health-care professionals. A worldwide call to action. Bakris, G., Hill, M., Mancia, G., Steyn, K., Black, H.R., Pickering, T., De Geest, S., Ruilope, L., Giles, T.D., Morgan, T., Kjeldsen, S., Schiffrin, E.L., Coenen, A., Mulrow, P., Loh, A., Mensah, G. J. Hum. Hypertens (2008) [Pubmed]
  5. Slowing nephropathy progression: focus on proteinuria reduction. Bakris, G.L. Clinical J. American Society Nephrology : Cjasn (2008) [Pubmed]
  6. Current perspectives on hypertension and metabolic syndrome. Bakris, G.L. J. Manag. Care. Pharm (2007) [Pubmed]
  7. Atlas vertebra realignment and achievement of arterial pressure goal in hypertensive patients: a pilot study. Bakris, G., Dickholtz, M., Meyer, P.M., Kravitz, G., Avery, E., Miller, M., Brown, J., Woodfield, C., Bell, B. J. Hum. Hypertens (2007) [Pubmed]
  8. Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers. Bakris, G.L., Cooper-Dehoff, R.M., Zhou, Q., Kupfer, S., Champion, A., Pepine, C.J. Am. J. Cardiovasc. Drugs (2007) [Pubmed]
  9. Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: results of the IMPROVE trial. Bakris, G.L., Ruilope, L., Locatelli, F., Ptaszynska, A., Pieske, B., de Champlain, J., Weber, M.A., Raz, I. Kidney Int. (2007) [Pubmed]
  10. Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in type 2 diabetes patients with microalbuminuria. Bakris, G.L., Ruilope, L.M., McMorn, S.O., Weston, W.M., Heise, M.A., Freed, M.I., Porter, L.E. J. Hypertens. (2006) [Pubmed]
  11. Cardiovascular risk factors in hypertension: rationale and design of studies to investigate the effects of controlled-release carvedilol on regression of left ventricular hypertrophy and lipid profile. Bakris, G.L., Tarka, E.A., Waterhouse, B., Goulding, M.R., Madan, A., Anderson, K.M., St John Sutton, M., Miller, A.B., Reichek, N. Am. J. Cardiol. (2006) [Pubmed]
  12. Comparative antihypertensive efficacy of angiotensin receptor blocker-based treatment in African-American and white patients. Bakris, G.L., Smith, D.H., Giles, T.D., White, W.B., Davidai, G., Weber, M.A. J. Clin. Hypertens. (Greenwich) (2005) [Pubmed]
  13. Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes. Bakris, G.L., Fonseca, V., Katholi, R.E., McGill, J.B., Messerli, F., Phillips, R.A., Raskin, P., Wright, J.T., Waterhouse, B., Lukas, M.A., Anderson, K.M., Bell, D.S. Hypertension (2005) [Pubmed]
  14. Inclusion of albuminuria in hypertension and heart guidelines. Bakris, G. Kidney Int. Suppl. (2004) [Pubmed]
  15. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Bakris, G.L., Weir, M.R., Shanifar, S., Zhang, Z., Douglas, J., van Dijk, D.J., Brenner, B.M. Arch. Intern. Med. (2003) [Pubmed]
 
WikiGenes - Universities